Several studies have shown that major cause of cancers are exposure to environmental and/or lifestyle factors while only up to 10 % of total cancer are due to inborn genetic defects . The excess reactive oxygen species (ROS) due to stress and other inflammatory disease may cause of cancer. ROS induced DNA instability which triggers many adverse metabolic pathways that involve in conversion of normal cells into tumor cells. Further, ROS can also be responsible for base changes leading to mutations which initiate tumor formation. These oxidative stresses could be reduced by plant-based phytochemicals agents. Recent studies in the field of drug discovery have shown that dietary phytochemicals have potential to inhibit carcinogenic process by interfering with one or multiple cellular pathways and hence play an important role in cancer chemoprevention . These phytochemicals act on the molecular targets of cancer and have therapeutics importance. Tyrosine-kinase inhibitors and other drugs with anti-angiogenic properties are currently undergoing preclinical investigations for their anticancerous activity .